Usefulness of Hepatic Artery Injection of Iodized Oil and ¹³¹I-Labeled Iodized Oil before the Therapeutic Decision in Hepatocellular Carcinoma

References

• The liver cancer study group of Japan. Primary liver cancer in Japan. Cancer 1984; 54: 1747–55
   PubMedGoogle Scholar
• Lee C S, Sung J L, Hwang L Y, et al. Surgical treatment of 109 patients with symptomatic and asymptomatic hepatocellular carcinoma. Surgery 1986; 99: 481–90
   PubMedGoogle Scholar
• Maki S, Konno T, Maeda H. Image enhancement in computerized tomography for sensitive diagnosis of liver cancer and semiquantitation of tumor selective drug targeting with oily contrast medium. Cancer 1985; 56: 751–7
   PubMed Web of Science ®Google Scholar
• Nakakuma K, Tashiro S, Hiraoka T, Ogata K, Ootsuka K. Hepatocellular carcinoma and metastatic cancer detected by iodized oil. Radiology 1985; 154: 15–7
   PubMed Web of Science ®Google Scholar
• Yumoto Y, Jinno K, Tokuyama, et al. Hepatocellular carcinoma detected by iodized oil. Radiology 1985; 154: 19–24
   PubMed Web of Science ®Google Scholar
• Raoul J L, Duvauferrier R, Bourguet P, et al. L'angiographie lipiodolee au cours des carcinomes hepatocellulaires. Apport du Lipiodol marqué à l'iode 131. J Radiol 1986; 67: 797–801
   PubMedGoogle Scholar
• Iwai K, Maeda H, Konno T. Use of oily contrast medium for selective drug targeting to tumor: enhanced therapeutic effect and X-ray image. Cancer Res 1984; 44: 2115–21
   PubMed Web of Science ®Google Scholar
• Raoul J L, Bourguet P, Bretagne J F, et al. Hepatic artery injection of I-131-labeled Lipiodol. I. Biodistribution study results in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 541–5
   PubMed Web of Science ®Google Scholar
• Konno T, Maeda H, Iwai K, et al. Effect of arterial administration of high-molecular-weight anticancer agent SMANCS with lipid lymphographic agent on hepatoma:a preliminary report. Eur J Cancer Clin Oncol 1983; 19: 1053–65
   PubMedGoogle Scholar
• Konno T, Maeda H, Iwai K, et al. Selective targeting of anticancer drug and simultaneous image enhancement in solid tumors by arterially administered lipid contrast medium. Cancer 1984; 54: 2367–74
   PubMed Web of Science ®Google Scholar
• Ohishi H, Uchida H, Yoshimura H, et al. Hepatocellular carcinoma detected by iodized oil. Use of anticancer agents. Radiology 1985; 154: 25–9
   PubMed Web of Science ®Google Scholar
• Kobayashi H, Hidaka H, Kajiya Y, et al. Treatment of hepatocellular carcinoma by transarterial injection of anticancer agents in iodized oil suspension or of radioactive iodized oil solution. Acta Radiol [Diagn] (Stockh) 1986; 27: 139–47
   PubMedGoogle Scholar
• Bretagne J F, Raoul J L, Bourguet P, et al. Hepatic artery injection of I-131-labeled Lipiodol. II. Preliminary results of therapeutic use in patients with hepatocellular carcinoma and liver metastases. Radiology 1988; 168: 547–50
   PubMedGoogle Scholar
• Raoul J L, Bretagne J F, Caucanas J P, et al. Internal radiation therapy for hepatocellular carcinoma. Results of a French multi-center phase II trial of transarterial injection of iodine 131-labeled Lipiodol. Cancer 1992; 69: 346–52
   PubMedGoogle Scholar
• Hayashi N, Yamamoto K, Tamaki N, et al. Metastatic nodules of hepatocellular carcinoma:detection with angiography, CT, and US. Radiology 1987; 165: 61–3
   PubMedGoogle Scholar
• Merine D, Takayasu K, Wakao F. Detection of hepatocellular carcinoma:comparison of CT during arterial portography with CT after intraarterial injection of iodized oil. Radiology 1990; 175: 707–10
   PubMedGoogle Scholar
• Kemeny F, Vadrot J, Wu A, Smadja C, Meakins J L, Franco D. Morphological and histological features of resected hepatocellular carcinoma in cirrhotic patients in the West. Hepatology 1989; 9: 253–7
   PubMedGoogle Scholar
• Kanematsu T, Inokuchi K, Sugimachi K, et al. Selective effect of Lipiodolized antitumor agents. J Surg Oncol 1984; 25: 218–26
   PubMed Web of Science ®Google Scholar
• Takayasu K, Shima Y, Muramatsu Y, et al. Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 1987; 162: 345–51
   PubMedGoogle Scholar
• Sasaki Y, Imaoka S, Fujita M, et al. Regional therapy in the management of intrahepatic recurrence after surgery for hepatoma. Ann Surg 1987; 206: 40–7
   PubMedGoogle Scholar
• Kanematsu T, Furuta T, Matsumata T, et al. A 5-year experience of Lipiodolization: selective regional chemotherapy for 200 patients with hepatocellular carcinoma. Hepatology 1989; 10: 98–102
   PubMed Web of Science ®Google Scholar
• Bismuth H, Morino M, Sherlock D, et al. Primary treatment of hepatocellular carcinoma by arterial chemoembolization. Am J Surg 1992; 163: 387–94
   PubMedGoogle Scholar
• Raoul J L, Heresbach D, Bretagne J F, et al. Chemoembolization of hepatocellular carcinomas. A study of the biodistribution and pharmacokinetics of doxorubicin. Cancer 1992; 70: 585–90
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Imaoka S, Kasugai H, et al. A new approach to chemoembolization therapy for hepatoma using ethiodized oil, cisplatin, and gelatin sponge. Cancer 1987; 60: 1194–203
   PubMed Web of Science ®Google Scholar
• Kasugai H, Kojima J, Tatsuta M, et al. Treatment of hepatocellular carcinoma by transcatheter arterial embolization combined with intraarterial infusion of a mixture of cisplatin and ethiodized oil. Gastroenterology 1989; 97: 965–71
   PubMed Web of Science ®Google Scholar
• Shibata J, Fujiyama S, Sato T, Kishimoto S, Fukushima S, Nakano M. Hepatic arterial injection chemotherapy with cisplatin suspended in an oily lymphographic agent for hepatocellular carcinoma. Cancer 1989; 64: 1586–94
   PubMed Web of Science ®Google Scholar
• Beppu T, Ohara C, Yamaguchi Y, et al. A new approach to chemoembolization for unresectable hepatocellular carcinoma using Aclarubicin microspheres in combination with Cisplatin suspended in iodized oil. Cancer 1991; 68: 2555–60
   PubMedGoogle Scholar
• Konno T, Maeda H. Targeting chemotherapy of hepatocellular carcinoma. Arterial administration of SMANCS/Lipiodol. Neoplasms of the liver, K Okuda, K G Ishak. Springer-Verlag, Heidelberg 1987; 343–52
   Google Scholar
• Hepatocellular carcinoma. An atlas of its pathology, T Nakashima, M Kojiro. Springer-Verlag, Heidelberg 1987; 117–9
   Google Scholar
• Wakasa K, Sakurai M, Monden M, et al. Necrosis of portal tumor embolus of hepatocellular carcinoma by Lipiodol trans-catheter chemoembolization. A case report. Acta Pathol Jpn 1988; 38: 1363–7
   PubMedGoogle Scholar
• Livraghi T, Grigioni W, Mazziotti A, Sangalli G, Vettori C. Percutaneous alcohol injection of portal thrombosis in hepatocellular carcinoma:a new possible treatment. Tumori 1990; 76: 394–7
   PubMedGoogle Scholar